Highest-materiality recent filing
NY court allows James River's breach-of-contract damages claim against Fleming to proceed
Supreme Court, New York County granted in part and denied in part Fleming's motion to dismiss on June 13, 2026.
James River appoints Rajiv Basu to board; Dennis Langwell resigns
Dennis Langwell resigned as director effective June 16, 2026, not due to any disagreement with the company.
James River Group issues Q1 2026 investor presentation; details not provided in filing excerpt
Investor presentation for Q1 2026 furnished as Exhibit 99.1; dated May 2026.
James River Q1 2026 net loss $0.23/share vs prior year profit; adjusted net operating income $0.12
Net loss from continuing ops of $10.7M ($0.23 loss per share) vs income of $9.0M ($0.18 EPS) in Q1 2025.
Director Dennis J. Langwell will not seek re-election at JRVR 2026 annual meeting
Dennis J. Langwell notified the Company on April 8, 2026, of his decision not to stand for re-election.
James River Group furnishes Q4 2025 investor presentation; no specific data in excerpt
Investor presentation for Q4 2025 furnished as Exhibit 99.1.
James River raises CEO Frank D'Orazio's STI target to 150%, LTI target to 200% of base salary
Effective March 2, 2026, CEO Frank D'Orazio's target STI award increased from 100% to 150% of base salary.
James River posts Q4 net income of $30.1M vs loss of $94M YoY; combined ratio improves to 94.1%
Q4 2025 net income from continuing ops $30.15M ($0.53/diluted) vs loss of $92.67M ($2.25) in Q4 2024.
James River secures denial of Fleming's motion for reconsideration in securities fraud suit
U.S. District Court, Southern District of New York denied Fleming's motion for reconsideration on Dec 2, 2025.
Q3 2025 investor presentation furnished; no financial details available in filing text
Filing only contains 8-K cover and exhibit index; actual presentation slides not reproduced.
James River Group Holdings redomiciles from Bermuda to Delaware, effective Nov 7, 2025
Renamed to James River Group Holdings, Inc.; former Bermuda entity discontinued.
James River Q3 net loss narrows to $0.01/share; adj net op income $0.32; $0.01 dividend
Net loss from continuing ops of $(0.01)/share vs $(1.07) YoY; adjusted net op income $0.32 vs $(0.74).
All 8 director nominees elected; votes ranged from 33.3M to 33.7M for (excluding broker non-votes).
James River Group Holdings' Specialty Admitted President Bowman to retire; Binnie named successor
William K. Bowman, President and CEO of the Specialty Admitted segment, intends to retire on September 30, 2025.
Richard Schmitzer stepped down as CEO of Excess & Surplus Lines segment effective July 31, 2025; remains as SVP Underwriting through Oct 15, 2025.
James River Group furnishes Q2 2025 investor presentation; no specific figures in excerpt
Furnished investor presentation for Q2 2025 under Item 7.01; intended for meetings with investors and analysts.
James River Q2 net income $0.07/sh, adj. op. income $0.23; declares $0.01 dividend
Net income from continuing ops $3.2M ($0.07 diluted); adjusted net operating income $11.7M ($0.23).
James River appoints Joel D. Cavaness to board as independent director
Joel Cavaness appointed to James River board effective July 21, 2025.
James River Group wins dismissal of Fleming securities fraud lawsuit
U.S. District Court, Southern District of New York granted dismissal on July 17, 2025.
James River Group enters new $212.5M unsecured credit facility maturing June 2028
New $212.5M unsecured revolving credit facility replaces prior $212.5M unsecured and $45M secured facilities.
James River Group furnishes Q1 2025 investor presentation; detailed results not in filing excerpt
Company furnished a Q1 2025 investor presentation under Regulation FD; no financial data in the filing body.
James River Q1 EPS drops 66% YoY; E&S president retires; $0.01 dividend declared
Q1 net income from continuing ops $9.0M ($0.18 diluted), down from $20.9M ($0.53) YoY; adjusted net op income $9.1M ($0.19)
JRG Re sale price dispute resolved: only $483,625 adjustment, far below Fleming's $54.1M claim
Independent Accounting Firm ruled on disputed items from JRG Re sale: $483,625 downward adjustment, vs. Fleming's $54.1M claim.
James River Group Holdings furnishes Q4 2024 investor presentation; no material new facts disclosed
Company furnished its Q4 2024 investor presentation under Item 7.01 Regulation FD.
James River Board approves discretionary increase in 2024 STI payouts for top executives
CEO Frank D'Orazio receives $745,268 (77.1% of target) under adjusted STI Plan.
James River Q4 2024 net loss $92.7M ($2.25/share); adjusted loss $40.8M
Net loss from continuing ops $92.7M ($2.25/diluted) vs income $17.4M ($0.46) in Q4 2023.
James River Group wins dismissal of securities class action with prejudice
U.S. District Court (SDNY) dismissed with prejudice the class action filed Nov 13, 2023 by Paul Glantz.
James River Group furnishes Q3 2024 investor presentation; no financial details in filing text
Q3 2024 investor presentation furnished on December 6, 2024 under Item 7.01.
Exchanged 37,500 Series A Preferred for 5.9M common shares at $6.40/share; private placement of 1.95M shares to Cavello Bay for $12.5M.
James River Q3 net loss $1.10/dil; $52.2M E&S ADC charge drives loss
Net loss from continuing ops $40.7M ($1.07/dil); net loss available to common $42.0M ($1.10/dil).
JRVR shareholders approve increase in shares for equity incentive plans
LTIP share pool increased by 525,000 to 5,507,650 total shares authorized.
James River Q2 adjusted EPS $0.33 (up 83% YoY); E&S combined ratio 95.4%; dividend $0.05
Net income from continuing ops $11.9M ($0.31 diluted), vs $9.5M ($0.25) in Q2 2023.
JRVR approves $1.57M retention awards for 3 NEOs; amends CEO severance to include STI target
Retention awards of aggregate ~$1.57M approved for three named executive officers, payable in 2024/2025 installments.
James River completes $160M LPT-ADC reinsurance with State National
State National reinsures 85% of E&S losses above $716.6M up to $467.1M limit; premium $313.2M.
James River Q1 net income from continuing ops $20.9M ($0.53 EPS) vs $5.3M ($0.14) YoY
Adjusted net operating income $14.8M ($0.39 diluted) vs $15.0M ($0.40) YoY.
James River completes sale of JRG Re for ~$291.4M; Heinlein departs
Closed sale of JRG Re to Fleming Intermediate Holdings for total consideration of ~$291.4M.
New York Supreme Court ordered Fleming to complete acquisition of JRG Reinsurance Company Ltd. by April 16, 2024.
James River sues Fleming to enforce sale of JRG Reinsurance subsidiary
Filed complaint in NY Supreme Court against Fleming Intermediate Holdings for breach of Stock Purchase Agreement dated Nov 8, 2023.
Board approved discretionary increase to STI payouts, adjusting for strategic activities including sale of renewal rights, JRG Re transaction, and strategic alternatives.
James River Q4 net loss $152.8M on JRG Re discontinued ops; sells reinsurer in Q1 2024
Net loss from discontinued ops of $170.2M includes $80.4M held-for-sale loss and $53.2M on fixed maturities.
James River Group settles separation agreement with departing segment CEO McCafferty
Terminated segment CEO McCafferty receives pro-rated STIP/LTIP awards based on 2023 performance and service period.
James River reaches agreement in principle to settle securities class action; insurers to pay
Agreement in principle reached Dec. 7, 2023 to settle Employees’ Retirement Fund of the City of Fort Worth v. James River Group Holdings, Ltd., Case 3:21-cv-00444-DJN.
James River replaces McCafferty with Bowman as President and CEO of Specialty Admitted Insurance
Terence M. McCafferty left as President and CEO of Specialty Admitted Insurance segment effective Dec 2, 2023.
James River board launches strategic alternatives review, including potential sale
Board will consider a wide range of options including sale, merger, or other strategic transaction.
James River Group sells JRG Reinsurance to Fleming Intermediate for up to $279.5M
Total consideration: $138M cash at closing, $139M pre-closing dividend/return of capital, plus up to $2.5M contingent payment.
James River restates Q1/Q2 2023 financials due to reinsurance premium error; Q3 net income $16.9M
Error in reinstatement premium accounting overstated net income by $7.8M (Q1) and $10.4M (H1 2023).
James River Group sells casualty reinsurance unit to Fleming for $277M
Total estimated transaction value of $277M, including $139M pre-closing dividend and $138M cash at close.
James River sells Individual Risk Workers' Compensation renewal rights to Amynta Group
IRWC business produced $53M gross written premiums in 2022; includes full operations and employee transfer.
Core E&S renewal rates up 11% in Q2 2023, 26th consecutive quarter of increases.
James River Q2 net income $21.1M ($0.54 EPS) vs $5.0M; growth in premiums and investment income
Net income $21.1M ($0.54 diluted) vs $5.0M ($0.13) in Q2 2022; adjusted net operating income $20.6M ($0.53) vs $20.0M ($0.52).
On June 2, 2026, Mr. Langwell advised the Company of his resignation as a director of the Company, with effect from June 16, 2026.
Todd Sutherland will succeed him as President, also effective immediately.
On May 5, 2025, the Company announced that Richard J. Schmitzer, President and Chief Executive Officer of the Company’s Excess & Surplus Lines segment, in anticipation of his retirement from the Company later this year, will relinquish his President title effective immediately.
Mr. Schmitzer will also step down as Chief Executive Officer of the Company’s Excess & Surplus Lines segment, effective on July 31, 2025.
On February 27, 2025, Ollie L. Sherman, Jr. tendered his resignation as a director of the Company, with effect from April 30, 2025.
the Board named Christine LaSala, a current director, as the successor Non-Executive Chairperson of the Board, effective February 20, 2025.
On July 5, 2024, the Board of Directors (the “ Board ”) of the Company appointed Christine LaSala as a director of the Company.
On May 6, 2024, Patricia H. Roberts tendered her resignation as a director of the Company, with effect from May 15, 2024.
In connection with the Transaction, as of April 16, 2024, Daniel J. Heinlein, President and Chief Executive Officer of JRG Re, joined Buyer, and is no longer employed by a subsidiary of the Company.
As previously announced, Terence M. McCafferty, President and Chief Executive Officer of the Specialty Admitted Insurance segment of James River Group Holdings, Ltd. (the “Company”), left the Company effective December 2, 2023 (the “Separation Date”).
Effective December 2, 2023, Terence M. McCafferty, President and Chief Executive Officer of the Specialty Admitted Insurance segment of James River Group Holdings, Ltd. (the “Company”), is no longer with the Company.
On June 4, 2023, J. Adam Abram, the Non-Executive Chairman of the Board of James River Group Holdings, Ltd. (the “ Company ”), advised the Company that he does not intend to seek re-election as a director at the Company’s 2023 annual general meeting of shareholders
Max materiality 0.85 · Median 0.55 · Most common event other_material